menopause

Cash-strapped Acer sees menopause drug flunk phase 2 trial
Cash-strapped Acer sees menopause drug flunk phase 2 trial
Fierce Biotech
Acer Therapeutics
clinical trials
hot flashes
menopause
osanetant
Flag link:
Astellas has menopause accelerated approval ambition thwarted by FDA at last minute
Astellas has menopause accelerated approval ambition thwarted by FDA at last minute
Fierce Biotech
Astellas
menopause
fezolinetant
FDA
Flag link:
Astellas buys Super Bowl commercial spot to raise menopause awareness
Astellas buys Super Bowl commercial spot to raise menopause awareness
Medical Marketing and Media
Astellas
menopause
Super Bowl
DTC advertising
television ads
fezolinetant
Flag link:
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
Endpoints
Astellas
hot flashes
menopause
fezolinetant
patient education
Flag link:
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Clinical Trials Arena
Astellas
clinical trials
menopause
China
fezolinetant
vasomotor symptoms
hot flashes
Flag link:
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Fierce Biotech
Astellas
menopause
FDA
clinical trials
Asia
fezolinetant
hot flashes
Flag link:
Astellas' menopause drug suffers rare setback as failed Asian trial blots previously pristine record
Astellas' menopause drug suffers rare setback as failed Asian trial blots previously pristine record
Fierce Biotech
Astellas
menopause
hot flashes
clinical trials
fezolinetant
Flag link:
Astellas’ eyes filings for menopause drug fezolinetant after ph3 win
Astellas’ eyes filings for menopause drug fezolinetant after ph3 win
Pharmaforum
Astellas
menopause
clinical trials
fezolinetant
hot flashes
Flag link:
Amyris to buy women’s wellness firm MenoLabs
Amyris to buy women’s wellness firm MenoLabs
Pharmaceutical Business Review
Amyris
MenoLabs
menopause
M&A
Women's Health
Flag link:
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
Fierce Biotech
Mithra
clinical trials
menopause
FDA
hot flashes
Flag link:
Meet 8 Female Founders Disrupting The $600 Billion Menopause Market
Meet 8 Female Founders Disrupting The $600 Billion Menopause Market
Forbes
Women's Health
menopause
Flag link:
Astellas scores a pair of trial wins for menopausal hot flash med, raising the pitch of looming Bayer standoff
Astellas scores a pair of trial wins for menopausal hot flash med, raising the pitch of looming Bayer standoff
Endpoints
Astellas
clinical trials
fezolinetant
menopause
hot flashes
Flag link:
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Fierce Biotech
Bayer
KaNDy Therapeutics
M&A
Women's Health
menopause
hot flashes
NT-814
Flag link:
Astellas pushes non-hormonal menopause drug into phase 3
Astellas pushes non-hormonal menopause drug into phase 3
Pharmaforum
Astellas
menopause
clinical trials
fezolinetant
Flag link:
Concept Device Designed to Tame Menopausal Hot Flashes
Concept Device Designed to Tame Menopausal Hot Flashes
Medical Devices and Diagnostics Industry
devices
Cambridge Consultants
hot flashes
menopause
Flag link:
FDA approves TherapeuticsMD's menopause drug
FDA approves TherapeuticsMD's menopause drug
Yahoo/Reuters
TherapeuticsMD
menopause
Bijuva
Flag link:
Women’s health firm KaNDy raises $32M for menopause study
Women’s health firm KaNDy raises $32M for menopause study
Fierce Biotech
KaNDy Therapeutics
clinical trials
menopause
NT-814
Flag link:
FDA approves TherapeuticsMD's hormone therapy
FDA approves TherapeuticsMD's hormone therapy
Yahoo/Reuters
FDA
TherapeuticsMD
menopause
Imvexxy
vaginal atrophy
Flag link:
Shire's Vyvanse could bag another lucrative new market in menopausal women
Shire's Vyvanse could bag another lucrative new market in menopausal women
Fierce Pharma Marketing
Shire
menopause
Vyvanse
Flag link:
Mylan Launches First Generic Version of Menopause Treatment
Mylan Launches First Generic Version of Menopause Treatment
Drug Discovery and Development
Mylan Labs
generics
menopause
Novartis
Vivelle-Dot
Flag link:

Pages